Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Hy-122359as
2. Cs-0371574
Molecular Weight | 463.6 g/mol |
---|---|
Molecular Formula | C30H35NO3 |
XLogP3 | 6.2 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 7 |
Exact Mass | 463.29935445 g/mol |
Monoisotopic Mass | 463.29935445 g/mol |
Topological Polar Surface Area | 30.9 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 619 |
Isotope Atom Count | 6 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
About the Company : Anthem Biosciences is a leading contract research and innovation service provider (CRISP) in Bengaluru, India, which manufactures novel drug actives. Established in 2007, it specia...
About the Company : FandaChem, headquartered in Hangzhou, China, is a reputable supplier and exporter of chemicals with a focus on delivering high-quality products. Our expertise lies in exporting a w...
About the Company : Hoventa Pharma is in the business of manufacturing APIs for over three decades.We offer various kinds of services in addition to supplies of APIs, we undertake long-term contracts ...
Market Place
Reply
28 Sep 2024
Reply
07 Feb 2019
ABOUT THIS PAGE
A Ormeloxifene manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ormeloxifene, including repackagers and relabelers. The FDA regulates Ormeloxifene manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ormeloxifene API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ormeloxifene manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ormeloxifene supplier is an individual or a company that provides Ormeloxifene active pharmaceutical ingredient (API) or Ormeloxifene finished formulations upon request. The Ormeloxifene suppliers may include Ormeloxifene API manufacturers, exporters, distributors and traders.
click here to find a list of Ormeloxifene suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Ormeloxifene Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ormeloxifene GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ormeloxifene GMP manufacturer or Ormeloxifene GMP API supplier for your needs.
A Ormeloxifene CoA (Certificate of Analysis) is a formal document that attests to Ormeloxifene's compliance with Ormeloxifene specifications and serves as a tool for batch-level quality control.
Ormeloxifene CoA mostly includes findings from lab analyses of a specific batch. For each Ormeloxifene CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ormeloxifene may be tested according to a variety of international standards, such as European Pharmacopoeia (Ormeloxifene EP), Ormeloxifene JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ormeloxifene USP).
LOOKING FOR A SUPPLIER?